ConditionRefractive Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-50
Sponsor59th Medical Wing
About this trial
This is a prospective randomized contralateral double-masked study. Each patient will be randomized as to which eye undergoes wave-front optimized (WFO) vs. wave-front guided (WFG) during Photorefractive keratectomy (PRK) or Laser-assisted in situ Keratomileusis (LASIK) surgery to determine which ablation profile provides the best visual outcome.
Eligibility criteria
Qualifiers
Meet requirements for PRK or LASIK i.e., Stable <= .5 D change MRSE)
DOD beneficiaries age 21-50 years
Local pts (w/i 60 mi) who will be in the area for at least 6 months post surgery
Willing to complete all required follow-up visits
Disqualifiers
No meeting requirements for PRK or LASIK
Desiring monovision treatment
Anisometropia >2D spherical equivalent
Prior ocular surgeries / trauma / problem
Trial design
Treatments tested in this trial
- Wave-Front Optimized (WFO) ablation vs Topography-guided (TG) ablation
Treatment groups
400 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov